Letters
US authority approves more efficacious hepatitis C drug
Sofosbuvir's prohibitive cost will put it out of reach of most patients in developing countries, including India
US $50 million to protect biodiversity in India
Manmohan Singh says the challenge is to develop new models of inclusive conservation
The hunt for benefits
India is hailed as a pioneer in implementing the third objective of the Convention on Biological Diversity—fair and equitable sharing of …
The International Year of Millets is an opportunity to improve indigenous kids’ nutrition
About 4.7 million tribal children in the country suffer from chronic nutrition deprivation
Veggies delight
The rising demand for vegetables has opened up a money-making opportunity for small farmers. Already reeling from recurring droughts and …
Andhra Pradesh cancels land allotted for SEZ in Anantapur
The company, Lepakshi Knowledge Hub Limited, mortgaged land for bank loans violating MoU
World Water Week 2023: We must invest in natural solutions like spring revival for water security
Time to move away from a hard-engineering approach and embrace nature-based solutions for water security in hill and mountain communities
Patent claim on hepatitis C drug questioned in many countries
With hepatitis C killing at least 700,000 people every year, civil society has strengthened efforts to make the drug accessible